Is Palantir Stock Set to Soar Again in the New Year?

Palantir rallied 340% in 2024 to a $167 billion market cap after accelerating revenue growth for five consecutive quarters, driven by demand for its AI analytics tools (Q3 U.S. commercial revenue +54% to $179m; U.S. government revenue +40% to $320m), while international growth lagged. The company now posts annual revenue above $2.5bn with GAAP net margin ~20% and operating margin ~16%; the piece projects a bull case of roughly $10bn revenue and ~$3bn earnings by 2029 if 30% growth and margin expansion continue, but notes the stock already trades at an outsized valuation (forward P/E >60; trailing P/S ~68). Given those elevated expectations, the article concludes the valuation appears disconnected from realistic near-term earnings and recommends avoiding new purchases of Palantir stock in 2025 despite ongoing momentum.

Analysis

Palantir rallied 340% in 2024 to a market capitalization of $167 billion after five consecutive quarters of accelerating revenue growth driven by demand for its AI analytics tools. In Q3 2024 U.S. commercial revenue rose 54% year‑over‑year to $179 million while U.S. government revenue increased 40% to $320 million; international government and commercial revenue growth lagged at 13% and 3%, respectively.

The company now reports annual revenue above $2.5 billion with GAAP net income margin near 20% and an operating margin of 16%; the article presents a bullish scenario in which 30% CAGR and margin expansion produce roughly $10 billion in revenue and ~$3 billion in earnings by 2029. That implied outcome is already priced into the stock, evidenced by a forward P/E above 60 and a trailing price‑to‑sales ratio of ~68 versus the S&P 500 forward P/E of 22, indicating elevated expectations.

If Palantir sustains quarter‑to‑quarter revenue acceleration the stock may keep rising in the near term, but current prices leave little margin for execution shortfalls. Key downside risks are persistent international weakness, a failure to sustain 30% growth or margin expansion, and valuation compression; the article's recommendation is to avoid buying shares in 2025 given the disconnect between price and realistic near‑term earnings.

Key Decisions for Investors

• Avoid initiating new long positions in PLTR at current valuations given a forward P/E >60 and trailing P/S ~68, consider waiting for meaningful valuation compression or clearer evidence of sustained global growth
• If already invested, trim exposure to manage downside risk and size positions so that a reversal in revenue momentum or margin trajectory (failure to continue quarter‑over‑quarter acceleration or miss on margin expansion toward the 30% scenario) does not force liquidation
• Monitor specific triggers for reassessment: at least two more quarters of sustained revenue acceleration, meaningful improvement in international commercial/government growth, and clear margin expansion toward the company’s bull case before adding to positions